TARA
TARA clinical trials: Protara Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Protara Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
TARA on the catalyst calendar · TARA registry changes
- Primary completion Apr 2028Sponsor estimatePhase 3NCT07480356Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With...Protara Therapeutics · Bladder (Urothelial, Transitional Cell) CancerRecruitingTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2028Sponsor estimatePhase 2/Phase 3NCT06910943Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral SupportProtara Therapeutics · Choline DeficiencyRecruitingTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2031Sponsor estimatePhase 2NCT05951179Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerProtara Therapeutics · Non-muscle Invasive Bladder CancerRecruitingTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 2NCT05871970Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18...Protara Therapeutics · Lymphatic MalformationRecruitingTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 12, 2024ActualPhase 1NCT05085990Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)Protara Therapeutics · Non-muscle Invasive Bladder CancerCompletedTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2024ActualPhase 1NCT05085977Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)Protara Therapeutics · Non-muscle Invasive Bladder CancerCompletedTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 29, 2023ActualNo phase registeredNCT05011370Prevalence of Liver Disease in Patients Dependent on Parenteral NutritionProtara Therapeutics · Intestinal Failure-associated Liver DiseaseCompletedTARALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner